LianBio Increase (Decrease) in Prepaid Expense and Other Assets
LianBio (LIANY) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$3.66 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2023-11-13
- LianBio increase (decrease) in prepaid expense and other assets for the quarter ending 2023-09-30 was $47.00K.
- LianBio increase (decrease) in prepaid expense and other assets for the quarter ending 2023-06-30 was -$3.55M.
- LianBio increase (decrease) in prepaid expense and other assets for the quarter ending 2023-03-31 was -$159.00K.
- LianBio increase (decrease) in prepaid expense and other assets for the quarter ending 2022-12-31 was $3.47M, a 20.78% decline year-over-year.
- LianBio increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$1.33M, a 116.24% decline from fiscal 2021.
- LianBio increase (decrease) in prepaid expense and other assets for fiscal 2021 was $8.18M, a 251.35% increase from fiscal 2020.
- LianBio increase (decrease) in prepaid expense and other assets for fiscal 2020 was $2.33M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2023-09-30 | $47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$3.50M derived: sum of 2 quarters · filed 2023-11-13 | -$3.66M 10-Q · filed 2023-11-13 | -$197.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | -$3.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$3.71M 10-Q · filed 2023-08-14 | -$244.00K derived: sum of 3 quarters · filed 2023-08-14 | -$1.91M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | -$159.00K 10-Q · filed 2023-05-11 | $3.31M derived: sum of 2 quarters · filed 2023-05-11 | $1.64M derived: sum of 3 quarters · filed 2023-11-13 | -$27.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | $3.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $1.80M derived: sum of 2 quarters · filed 2023-11-13 | $132.00K derived: sum of 3 quarters · filed 2023-11-13 | -$1.33M 10-K · filed 2023-03-28 |
| 2022-09-30 | -$1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$3.33M derived: sum of 2 quarters · filed 2023-11-13 | -$4.79M 10-Q · filed 2023-11-13 | -$419.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$3.13M 10-Q · filed 2023-08-14 | $1.25M derived: sum of 3 quarters · filed 2023-08-14 | $3.70M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$1.46M 10-Q · filed 2023-05-11 | $2.92M derived: sum of 2 quarters · filed 2023-05-11 | $5.37M derived: sum of 3 quarters · filed 2023-05-11 | $6.89M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $6.83M derived: sum of 2 quarters · filed 2023-03-28 | $8.35M derived: sum of 3 quarters · filed 2023-03-28 | $8.18M 10-K · filed 2023-03-28 |
| 2021-09-30 | $2.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $3.97M derived: sum of 2 quarters · filed 2022-11-10 | $3.80M 10-Q · filed 2022-11-10 | $4.88M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.34M 10-Q · filed 2022-08-11 | $2.42M derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$173.00K 10-Q · filed 2022-05-12 | $903.00K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $1.08M derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | $2.33M 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $1.25M 10-Q/A · filed 2022-01-10 |